| Preface |
|
xi | |
|
|
|
xiii | |
|
1 Amperometric Biosensors |
|
|
1 | (84) |
|
|
|
|
|
|
|
|
|
|
|
1 | (22) |
|
1.1.1 Definition of the Term "Biosensor" |
|
|
3 | (4) |
|
1.1.2 Milestones and Achievements Relevant to Biosensor Research and Development |
|
|
7 | (1) |
|
1.1.3 "First-Generation" Biosensors |
|
|
7 | (1) |
|
1.1.4 "Second-Generation" Biosensors |
|
|
7 | (6) |
|
1.1.5 "Third-Generation" Biosensors |
|
|
13 | (2) |
|
1.1.6 Reagentless Biosensor Architectures |
|
|
15 | (3) |
|
1.1.7 Parameters with a Major Impact on Overall Biosensor Response |
|
|
18 | (4) |
|
1.1.8 Application Areas of Biosensors |
|
|
22 | (1) |
|
1.2 Criteria for "Good" Biosensor Research |
|
|
23 | (2) |
|
1.3 Defining a Standard for Characterizing Biosensor Performances |
|
|
25 | (3) |
|
1.4 Success Stories in Biosensor Research |
|
|
28 | (27) |
|
1.4.1 Direct ET Employed for Biosensors and Biofuel Cells |
|
|
29 | (3) |
|
1.4.2 Direct ET with Glucose Oxidase |
|
|
32 | (4) |
|
1.4.3 Mediated ET Employed for Biosensors and Biofuel Cells |
|
|
36 | (2) |
|
1.4.4 Nanomaterials and Biosensors |
|
|
38 | (1) |
|
1.4.4.1 Modification of Macroscopic Transducers with Nanomaterials |
|
|
39 | (2) |
|
1.4.4.2 Nanometric Transducers |
|
|
41 | (1) |
|
1.4.4.3 Modification of Biomolecules with Nanomaterials |
|
|
42 | (1) |
|
1.4.5 Implanted Biosensors for Medical Research and Health Check Applications |
|
|
42 | (6) |
|
1.4.6 Nucleic Acid-Based Biosensors: Nucleic Acid Chips, Arrays, and Microarrays |
|
|
48 | (4) |
|
|
|
52 | (1) |
|
1.4.7.1 Labeled Approaches |
|
|
53 | (1) |
|
1.4.7.2 Nonlabeled Approaches |
|
|
54 | (1) |
|
|
|
55 | (30) |
|
|
|
56 | (1) |
|
|
|
57 | (1) |
|
|
|
57 | (4) |
|
|
|
61 | (24) |
|
2 Imaging of Single Biomolecules by Scanning Tunneling Microscopy |
|
|
85 | (58) |
|
|
|
|
|
|
|
|
|
|
|
85 | (2) |
|
2.2 Interfacial Electron Transfer in Molecular and Protein Film Voltammetry |
|
|
87 | (5) |
|
2.2.1 Theoretical Notions of Interfacial Chemical and Bioelectrochemical Electron Transfer |
|
|
88 | (2) |
|
2.2.2 Nuclear Reorganization Free Energy |
|
|
90 | (1) |
|
2.2.3 Electronic Tunneling Factor in Long-Range Interfacial (Bio)electrochemical Electron Transfer |
|
|
90 | (2) |
|
2.3 Theoretical Notions in Bioelectrochemistry towards the Single-Molecule Level |
|
|
92 | (5) |
|
2.3.1 Biomolecules in Nanoscale Electrochemical Environment |
|
|
92 | (1) |
|
2.3.2 Theoretical Frameworks and Interfacial Electron Transfer Phenomena |
|
|
92 | (1) |
|
2.3.2.1 Redox (Bio)molecules in Electrochemical STM and Other Nanogap Configurations |
|
|
93 | (2) |
|
2.3.2.2 New Interfacial (Bio)electrochemical Electron Transfer Phenomena |
|
|
95 | (2) |
|
2.4 In Situ Imaging of Bio-related Molecules and Linker Molecules for Protein Voltammetry with Single-Molecule and Sub-molecular Resolution |
|
|
97 | (10) |
|
2.4.1 Imaging of Nucleobases and Electronic Conductivity of Short Oligonucleotides |
|
|
97 | (1) |
|
2.4.2 Functionalized Alkanethiols and the Amino Acids Cysteine and Homocysteine |
|
|
98 | (2) |
|
2.4.2.1 Functionalized Alkanethiols as Linkers in Metalloprotein Film Voltammetry |
|
|
100 | (2) |
|
2.4.2.2 In Situ STM of Cysteine and Homocysteine |
|
|
102 | (2) |
|
2.4.2.3 Theoretical Computations and STM Image Simulations |
|
|
104 | (1) |
|
2.4.3 Single-Molecule Imaging of Bio-related Small Redox Molecules |
|
|
105 | (2) |
|
2.5 Imaging of Intermediate-Size Biological Structures: Lipid Membranes and Insulin |
|
|
107 | (5) |
|
2.5.1 Biomimetic Mono- and Bilayer Membranes on Au(111) Electrode Surfaces |
|
|
107 | (2) |
|
2.5.2 Monolayers of Human Insulin on Different Low-Index Au Electrode Surfaces Mapped to Single-Molecule Resolution by In Situ STM |
|
|
109 | (3) |
|
2.6 Interfacial Electrochemistry and In Situ Imaging of Redox Metalloproteins and Metalloenzymes at the Single-Molecule Level |
|
|
112 | (11) |
|
2.6.1 Metalloprotein Voltammetry at Bare and Modified Electrodes |
|
|
112 | (1) |
|
2.6.2 Single-Molecule Imaging of Functional Electron Transfer Metalloproteins by In Situ STM |
|
|
112 | (2) |
|
2.6.2.1 Small Redox Metalloproteins: Blue Copper, Heme, and Iron-Sulfur Proteins |
|
|
114 | (1) |
|
2.6.2.2 Single-Molecule Tunneling Spectroscopy of Wild-Type and Cys Mutant Cytochrome b562 |
|
|
114 | (2) |
|
2.6.2.3 Cytochrome c4: A Prototype for Microscopic Electronic Mapping of Multicenter Redox Metalloproteins |
|
|
116 | (3) |
|
2.6.2.4 Redox Metalloenzymes in Electrocatalytic Action Imaged at the Single-Molecule Level: Multicopper and Multiheme Nitrite Reductases |
|
|
119 | (1) |
|
2.6.2.5 Au-Nanoparticle Hybrids of Horse Heart Cytochrome c and P. aeruginosa Azurin |
|
|
120 | (3) |
|
2.7 Some Concluding Observations and Outlooks |
|
|
123 | (20) |
|
|
|
126 | (1) |
|
|
|
126 | (17) |
|
3 Applications of Neutron Reflectivity in Bioelectrochemistry |
|
|
143 | (46) |
|
|
|
|
|
143 | (1) |
|
3.2 Theoretical Aspects of Neutron Scattering |
|
|
144 | (10) |
|
|
|
144 | (1) |
|
3.2.2 Scattering from a Single Nucleus |
|
|
145 | (2) |
|
3.2.2.1 The Fermi Pseudo Potential |
|
|
147 | (1) |
|
3.2.3 Scattering from a Collection of Nuclei |
|
|
147 | (1) |
|
3.2.3.1 Neutron Scattering Cross Sections |
|
|
147 | (1) |
|
3.2.3.2 Coherent and Incoherent Scattering |
|
|
148 | (1) |
|
3.2.3.3 Effective Potential and Scattering Length Density |
|
|
148 | (1) |
|
3.2.4 Theoretical Expressions for Specular Reflectivity |
|
|
149 | (1) |
|
3.2.4.1 The Continuum Limit |
|
|
149 | (2) |
|
3.2.4.2 The Kinematic Approach |
|
|
151 | (3) |
|
|
|
154 | (14) |
|
3.3.1 Experimental Aspects of Reflectometer Operation |
|
|
154 | (3) |
|
3.3.2 Substrate Preparation and Characterization |
|
|
157 | (3) |
|
3.3.3 Cell Design and Assembly |
|
|
160 | (2) |
|
3.3.4 Data Acquisition and Analysis |
|
|
162 | (6) |
|
|
|
168 | (14) |
|
3.4.1 Supported Proteins, Peptides, and Membranes without Potential Control |
|
|
168 | (1) |
|
3.4.1.1 Quartz- and Silicon-Supported Bilayers |
|
|
168 | (2) |
|
3.4.1.2 Hybrid Bilayers on Solid Supports |
|
|
170 | (3) |
|
3.4.1.3 Protein Adsorption and DNA Monolayers |
|
|
173 | (2) |
|
3.4.2 Electric Field-Driven Transformations in Supported Model Membranes |
|
|
175 | (7) |
|
3.5 Summary and Future Aspects |
|
|
182 | (7) |
|
|
|
184 | (1) |
|
|
|
185 | (4) |
|
4 Model Lipid Bilayers at Electrode Surfaces |
|
|
189 | (40) |
|
|
|
|
|
|
|
189 | (1) |
|
4.2 Biomimetic Membranes: Scope and Requirements |
|
|
189 | (3) |
|
4.3 Electrochemical Impedance Spectroscopy |
|
|
192 | (2) |
|
4.4 Formation of Lipid Films in Biomimetic Membranes |
|
|
194 | (7) |
|
|
|
196 | (2) |
|
4.4.2 Langmuir-Blodgett and Langmuir-Schaefer Transfer |
|
|
198 | (2) |
|
4.4.3 Rapid Solvent Exchange |
|
|
200 | (1) |
|
4.4.4 Fluidity in Biomimetic Membranes |
|
|
201 | (1) |
|
4.5 Various Types of Biomimetic Membranes |
|
|
201 | (21) |
|
4.5.1 Solid-Supported Bilayer Lipid Membranes |
|
|
201 | (2) |
|
4.5.2 Tethered Bilayer Lipid Membranes |
|
|
203 | (1) |
|
4.5.2.1 Spacer-Based tBLMs |
|
|
204 | (1) |
|
4.5.2.2 Thiolipid-Based tBLMs |
|
|
205 | (10) |
|
4.5.2.3 Thiolipid-Spacer-Based tBLMs |
|
|
215 | (1) |
|
4.5.3 Polymer-Cushioned Bilayer Lipid Membranes |
|
|
216 | (2) |
|
4.5.4 S-Layer Stabilized Bilayer Lipid Membranes |
|
|
218 | (2) |
|
4.5.5 Protein-Tethered Bilayer Lipid Membranes |
|
|
220 | (2) |
|
|
|
222 | (7) |
|
|
|
223 | (1) |
|
|
|
223 | (6) |
|
|
|
229 | (40) |
|
|
|
|
|
|
|
229 | (6) |
|
5.1.1 Enzymatic Fuel Cell Design |
|
|
231 | (1) |
|
5.1.2 Enzyme Electron Transfer |
|
|
231 | (4) |
|
5.2 Bioanodes for Glucose Oxidation |
|
|
235 | (8) |
|
|
|
243 | (12) |
|
5.4 Assembled Biofuel Cells |
|
|
255 | (4) |
|
5.5 Conclusions and Future Outlook |
|
|
259 | (10) |
|
|
|
261 | (1) |
|
|
|
262 | (7) |
|
6 Raman Spectroscopy of Biomolecules at Electrode Surfaces |
|
|
269 | (66) |
|
|
|
|
|
|
|
269 | (1) |
|
|
|
270 | (2) |
|
6.3 SERS and Surface-Enhanced Resonant Raman Spectroscopy |
|
|
272 | (4) |
|
6.4 Comparison of SE(R)RS and Fluorescence for Biological Studies |
|
|
276 | (2) |
|
|
|
278 | (2) |
|
|
|
280 | (1) |
|
6.7 SERS Surfaces for Electrochemistry |
|
|
281 | (10) |
|
6.8 Tip-Enhanced Raman Spectroscopy |
|
|
291 | (1) |
|
6.9 SE(R)RS of Biomolecules |
|
|
292 | (23) |
|
6.9.1 DNA Bases, Nucleotides, and Their Derivatives |
|
|
292 | (4) |
|
6.9.2 DNA and Nucleic Acids |
|
|
296 | (3) |
|
6.9.3 Amino Acids and Peptides |
|
|
299 | (4) |
|
6.9.4 Proteins and Enzymes |
|
|
303 | (1) |
|
|
|
303 | (4) |
|
|
|
307 | (1) |
|
|
|
308 | (2) |
|
6.9.5 Membranes, Lipids, and Fatty Acids |
|
|
310 | (1) |
|
6.9.6 Metabolites and Other Small Molecules |
|
|
311 | (1) |
|
6.9.6.1 Neurotransmitters |
|
|
311 | (1) |
|
6.9.6.2 Nicotinamide Adenine Dinucleotide |
|
|
312 | (1) |
|
6.9.6.3 Flavin Adenine Dinucleotide |
|
|
313 | (2) |
|
|
|
315 | (1) |
|
|
|
315 | (1) |
|
|
|
315 | (20) |
|
|
|
316 | (19) |
|
7 Membrane Electroporation in High Electric Fields |
|
|
335 | (34) |
|
|
|
|
|
335 | (3) |
|
7.1.1 Giant Vesicles as Model Membrane Systems |
|
|
335 | (2) |
|
7.1.2 Mechanical and Rheological Properties of Lipid Bilayers |
|
|
337 | (1) |
|
7.2 Electrodeformation and Electroporation of Membranes in the Fluid Phase |
|
|
338 | (4) |
|
7.3 Response of Gel-Phase Membranes |
|
|
342 | (3) |
|
7.4 Effects of Membrane Inclusions and Media on the Response and Stability of Fluid Vesicles in Electric Fields |
|
|
345 | (5) |
|
7.4.1 Vesicles in Salt Solutions |
|
|
345 | (2) |
|
7.4.2 Vesicles with Cholesterol-Doped Membranes |
|
|
347 | (2) |
|
7.4.3 Membranes with Charged Lipids |
|
|
349 | (1) |
|
7.5 Application of Vesicle Electroporation |
|
|
350 | (7) |
|
7.5.1 Measuring Membrane Edge Tension from Vesicle Electroporation |
|
|
350 | (3) |
|
7.5.2 Vesicle Electrofusion |
|
|
353 | (1) |
|
7.5.2.1 Fusing Vesicles with Identical or Different Membrane Composition |
|
|
353 | (2) |
|
7.5.2.2 Vesicle Electrofusion: Employing Vesicles as Microreactors |
|
|
355 | (2) |
|
7.6 Conclusions and Outlook |
|
|
357 | (12) |
|
|
|
358 | (1) |
|
|
|
358 | (11) |
|
8 Electroporation for Medical Use in Drug and Gene Electrotransfer |
|
|
369 | (20) |
|
|
|
|
|
369 | (1) |
|
8.2 A List of Definitions |
|
|
370 | (1) |
|
8.3 How We Understand Permeabilization at the Cellular and Tissue Level |
|
|
371 | (3) |
|
8.4 Basic Aspects of Electroporation that are of Particular Importance for Medical Use |
|
|
374 | (3) |
|
|
|
374 | (1) |
|
|
|
375 | (1) |
|
8.4.3 Delivery of Other Molecules |
|
|
376 | (1) |
|
8.4.4 Delivery of Electric Pulses |
|
|
376 | (1) |
|
8.4.5 End of the Permeabilized State |
|
|
376 | (1) |
|
|
|
377 | (1) |
|
8.5 How to Deliver Electric Pulses in Patient Treatment |
|
|
377 | (1) |
|
8.5.1 Pulse Generators and Electrodes |
|
|
377 | (1) |
|
|
|
377 | (1) |
|
8.6 Treatment and Post-treatment Management |
|
|
378 | (1) |
|
8.7 Clinical Results with Electrochemotherapy |
|
|
378 | (2) |
|
8.7.1 Tumors Up to Three Centimeters in Size |
|
|
378 | (2) |
|
|
|
380 | (1) |
|
8.8 Use in Internal Organs |
|
|
380 | (1) |
|
|
|
381 | (1) |
|
|
|
381 | (1) |
|
8.8.3 Brain Metastases, Brain Tumors, and Other Tumors in Soft Tissues |
|
|
381 | (1) |
|
|
|
381 | (1) |
|
|
|
381 | (5) |
|
8.9.1 Gene Electrotransfer to Muscle |
|
|
383 | (1) |
|
8.9.2 Gene Electrotransfer to Skin |
|
|
383 | (1) |
|
8.9.3 Gene Electrotransfer to Tumors |
|
|
384 | (1) |
|
8.9.4 Gene Electrotransfer to Other Tissues |
|
|
385 | (1) |
|
|
|
386 | (3) |
|
|
|
386 | (3) |
| Index |
|
389 | |